Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

Blood (2017) 129 (18): 2587–2591.

https://doi.org/10.1182/blood-2016-11-751008

Published: 2017

Includes: Supplemental data

Journal Articles

NR4A3 Suppresses Lymphomagenesis I n Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1

Alexander JA Deutsch, PhD, Beate Rinner, Martin Pichler, Karoline Fechter, Hildegard T. Greinix, MD, Chenguang Wang, Christine Beham-Schmid, MD, Peter Neumeister, MD

Blood (2016) 128 (22): 2728.

https://doi.org/10.1182/blood.V128.22.2728.2728

Published: 2016

Journal Articles

NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy

Alexander JA Deutsch, PhD, Beate Rinner, PhD, Kerstin Wenzl, MSc, Katharina Troppan, MD, Beata Pursche, Hildegard T. Greinix, MD, Christine Beham-Schmid, MD, Peter Neumeister, MD

Blood (2015) 126 (23): 2674.

https://doi.org/10.1182/blood.V126.23.2674.2674

Published: 2015

Journal Articles

NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas

Alexander J. A. Deutsch, Beate Rinner, Kerstin Wenzl, Martin Pichler, Katharina Troppan, Elisabeth Steinbauer, Daniela Schwarzenbacher, Sonja Reitter, Julia Feichtinger, Sascha Tierling, Andreas Prokesch, Marcel Scheideler, Anne Krogsdam, Gerhard G. Thallinger, Helmut Schaider, Christine Beham-Schmid, Peter Neumeister

Blood (2014) 123 (15): 2367–2377.

https://doi.org/10.1182/blood-2013-08-518878

Published: 2014

Includes: Supplemental data

Journal Articles

NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.

Alexander JA Deutsch, Beate Rinner, Martin Pichler, Sonja Reitter, Christine Beham-Schmid, MD, Peter Neumeister

Blood (2012) 120 (21): 2408.

https://doi.org/10.1182/blood.V120.21.2408.2408

Published: 2012

Journal Articles

Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells

Alexander JA Deutsch, Beate Rinner, Heike Knausz, Werner Linkesch, Christine Beham-Schmid, Peter Neumeister

Blood (2010) 116 (21): 467.

https://doi.org/10.1182/blood.V116.21.467.467

Published: 2010

NARROW

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

NR4A3 Suppresses Lymphomagenesis I n Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1

NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy

NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas

NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.

Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells

Email alerts

ASH Publications

American Society of Hematology

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia

NR4A3 Suppresses Lymphomagenesis I n Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1

NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy

NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas

NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.

Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only